Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Tyrosine Protein Kinase JAK1 Market Growth 2022-2028

  • LP 4793303
  • 111 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Tyrosine Protein Kinase JAK1 will have significant change from previous year. According to our (LP Information) latest study, the global Tyrosine Protein Kinase JAK1 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tyrosine Protein Kinase JAK1 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Tyrosine Protein Kinase JAK1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tyrosine Protein Kinase JAK1 market, reaching US$ million by the year 2028. As for the Europe Tyrosine Protein Kinase JAK1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Tyrosine Protein Kinase JAK1 players cover AbbVie Inc, Aclaris Therapeutics Inc, Astellas Pharma Inc, and AstraZeneca Plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tyrosine Protein Kinase JAK1 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

AZD-4205

Baricitinib

Cerdulatinib

CJ-15314

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cutaneous Lupus Erythematosus

Eosinophilia

Hairy Cell Leukemia

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AbbVie Inc

Aclaris Therapeutics Inc

Astellas Pharma Inc

AstraZeneca Plc

Bristol-Myers Squibb Co

Chipscreen Biosciences Ltd

CJ HealthCare Corp

Concert Pharmaceuticals Inc

Eli Lilly and Co

Galapagos NV

Incyte Corp

Japan Tobacco Inc

Jiangsu Hengrui Medicine Co Ltd

Nissan Chemical Industries Ltd

Pfizer Inc

Portola Pharmaceuticals Inc

Sareum Holdings Plc

Theravance Biopharma Inc

Vectura Group Plc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tyrosine Protein Kinase JAK1 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Tyrosine Protein Kinase JAK1 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Tyrosine Protein Kinase JAK1 by Country/Region, 2017, 2022 & 2028

2.2 Tyrosine Protein Kinase JAK1 Segment by Type

2.2.1 AZD-4205

2.2.2 Baricitinib

2.2.3 Cerdulatinib

2.2.4 CJ-15314

2.2.5 Others

2.3 Tyrosine Protein Kinase JAK1 Sales by Type

2.3.1 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)

2.3.2 Global Tyrosine Protein Kinase JAK1 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Tyrosine Protein Kinase JAK1 Sale Price by Type (2017-2022)

2.4 Tyrosine Protein Kinase JAK1 Segment by Application

2.4.1 Cutaneous Lupus Erythematosus

2.4.2 Eosinophilia

2.4.3 Hairy Cell Leukemia

2.4.4 Others

2.5 Tyrosine Protein Kinase JAK1 Sales by Application

2.5.1 Global Tyrosine Protein Kinase JAK1 Sale Market Share by Application (2017-2022)

2.5.2 Global Tyrosine Protein Kinase JAK1 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Tyrosine Protein Kinase JAK1 Sale Price by Application (2017-2022)

3 Global Tyrosine Protein Kinase JAK1 by Company

3.1 Global Tyrosine Protein Kinase JAK1 Breakdown Data by Company

3.1.1 Global Tyrosine Protein Kinase JAK1 Annual Sales by Company (2020-2022)

3.1.2 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Company (2020-2022)

3.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue by Company (2020-2022)

3.2.1 Global Tyrosine Protein Kinase JAK1 Revenue by Company (2020-2022)

3.2.2 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company (2020-2022)

3.3 Global Tyrosine Protein Kinase JAK1 Sale Price by Company

3.4 Key Manufacturers Tyrosine Protein Kinase JAK1 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Tyrosine Protein Kinase JAK1 Product Location Distribution

3.4.2 Players Tyrosine Protein Kinase JAK1 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Tyrosine Protein Kinase JAK1 by Geographic Region

4.1 World Historic Tyrosine Protein Kinase JAK1 Market Size by Geographic Region (2017-2022)

4.1.1 Global Tyrosine Protein Kinase JAK1 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue by Geographic Region

4.2 World Historic Tyrosine Protein Kinase JAK1 Market Size by Country/Region (2017-2022)

4.2.1 Global Tyrosine Protein Kinase JAK1 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue by Country/Region

4.3 Americas Tyrosine Protein Kinase JAK1 Sales Growth

4.4 APAC Tyrosine Protein Kinase JAK1 Sales Growth

4.5 Europe Tyrosine Protein Kinase JAK1 Sales Growth

4.6 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Growth

5 Americas

5.1 Americas Tyrosine Protein Kinase JAK1 Sales by Country

5.1.1 Americas Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022)

5.1.2 Americas Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022)

5.2 Americas Tyrosine Protein Kinase JAK1 Sales by Type

5.3 Americas Tyrosine Protein Kinase JAK1 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tyrosine Protein Kinase JAK1 Sales by Region

6.1.1 APAC Tyrosine Protein Kinase JAK1 Sales by Region (2017-2022)

6.1.2 APAC Tyrosine Protein Kinase JAK1 Revenue by Region (2017-2022)

6.2 APAC Tyrosine Protein Kinase JAK1 Sales by Type

6.3 APAC Tyrosine Protein Kinase JAK1 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Tyrosine Protein Kinase JAK1 by Country

7.1.1 Europe Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022)

7.1.2 Europe Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022)

7.2 Europe Tyrosine Protein Kinase JAK1 Sales by Type

7.3 Europe Tyrosine Protein Kinase JAK1 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tyrosine Protein Kinase JAK1 by Country

8.1.1 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022)

8.2 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Type

8.3 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Tyrosine Protein Kinase JAK1

10.3 Manufacturing Process Analysis of Tyrosine Protein Kinase JAK1

10.4 Industry Chain Structure of Tyrosine Protein Kinase JAK1

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Tyrosine Protein Kinase JAK1 Distributors

11.3 Tyrosine Protein Kinase JAK1 Customer

12 World Forecast Review for Tyrosine Protein Kinase JAK1 by Geographic Region

12.1 Global Tyrosine Protein Kinase JAK1 Market Size Forecast by Region

12.1.1 Global Tyrosine Protein Kinase JAK1 Forecast by Region (2023-2028)

12.1.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Tyrosine Protein Kinase JAK1 Forecast by Type

12.7 Global Tyrosine Protein Kinase JAK1 Forecast by Application

13 Key Players Analysis

13.1 AbbVie Inc

13.1.1 AbbVie Inc Company Information

13.1.2 AbbVie Inc Tyrosine Protein Kinase JAK1 Product Offered

13.1.3 AbbVie Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Inc Main Business Overview

13.1.5 AbbVie Inc Latest Developments

13.2 Aclaris Therapeutics Inc

13.2.1 Aclaris Therapeutics Inc Company Information

13.2.2 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Offered

13.2.3 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Aclaris Therapeutics Inc Main Business Overview

13.2.5 Aclaris Therapeutics Inc Latest Developments

13.3 Astellas Pharma Inc

13.3.1 Astellas Pharma Inc Company Information

13.3.2 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Offered

13.3.3 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Astellas Pharma Inc Main Business Overview

13.3.5 Astellas Pharma Inc Latest Developments

13.4 AstraZeneca Plc

13.4.1 AstraZeneca Plc Company Information

13.4.2 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Offered

13.4.3 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AstraZeneca Plc Main Business Overview

13.4.5 AstraZeneca Plc Latest Developments

13.5 Bristol-Myers Squibb Co

13.5.1 Bristol-Myers Squibb Co Company Information

13.5.2 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Offered

13.5.3 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb Co Main Business Overview

13.5.5 Bristol-Myers Squibb Co Latest Developments

13.6 Chipscreen Biosciences Ltd

13.6.1 Chipscreen Biosciences Ltd Company Information

13.6.2 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Offered

13.6.3 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Chipscreen Biosciences Ltd Main Business Overview

13.6.5 Chipscreen Biosciences Ltd Latest Developments

13.7 CJ HealthCare Corp

13.7.1 CJ HealthCare Corp Company Information

13.7.2 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Offered

13.7.3 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 CJ HealthCare Corp Main Business Overview

13.7.5 CJ HealthCare Corp Latest Developments

13.8 Concert Pharmaceuticals Inc

13.8.1 Concert Pharmaceuticals Inc Company Information

13.8.2 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered

13.8.3 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Concert Pharmaceuticals Inc Main Business Overview

13.8.5 Concert Pharmaceuticals Inc Latest Developments

13.9 Eli Lilly and Co

13.9.1 Eli Lilly and Co Company Information

13.9.2 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Offered

13.9.3 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly and Co Main Business Overview

13.9.5 Eli Lilly and Co Latest Developments

13.10 Galapagos NV

13.10.1 Galapagos NV Company Information

13.10.2 Galapagos NV Tyrosine Protein Kinase JAK1 Product Offered

13.10.3 Galapagos NV Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Galapagos NV Main Business Overview

13.10.5 Galapagos NV Latest Developments

13.11 Incyte Corp

13.11.1 Incyte Corp Company Information

13.11.2 Incyte Corp Tyrosine Protein Kinase JAK1 Product Offered

13.11.3 Incyte Corp Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Incyte Corp Main Business Overview

13.11.5 Incyte Corp Latest Developments

13.12 Japan Tobacco Inc

13.12.1 Japan Tobacco Inc Company Information

13.12.2 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Offered

13.12.3 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Japan Tobacco Inc Main Business Overview

13.12.5 Japan Tobacco Inc Latest Developments

13.13 Jiangsu Hengrui Medicine Co Ltd

13.13.1 Jiangsu Hengrui Medicine Co Ltd Company Information

13.13.2 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Offered

13.13.3 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Jiangsu Hengrui Medicine Co Ltd Main Business Overview

13.13.5 Jiangsu Hengrui Medicine Co Ltd Latest Developments

13.14 Nissan Chemical Industries Ltd

13.14.1 Nissan Chemical Industries Ltd Company Information

13.14.2 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Offered

13.14.3 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Nissan Chemical Industries Ltd Main Business Overview

13.14.5 Nissan Chemical Industries Ltd Latest Developments

13.15 Pfizer Inc

13.15.1 Pfizer Inc Company Information

13.15.2 Pfizer Inc Tyrosine Protein Kinase JAK1 Product Offered

13.15.3 Pfizer Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Pfizer Inc Main Business Overview

13.15.5 Pfizer Inc Latest Developments

13.16 Portola Pharmaceuticals Inc

13.16.1 Portola Pharmaceuticals Inc Company Information

13.16.2 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered

13.16.3 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Portola Pharmaceuticals Inc Main Business Overview

13.16.5 Portola Pharmaceuticals Inc Latest Developments

13.17 Sareum Holdings Plc

13.17.1 Sareum Holdings Plc Company Information

13.17.2 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Offered

13.17.3 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Sareum Holdings Plc Main Business Overview

13.17.5 Sareum Holdings Plc Latest Developments

13.18 Theravance Biopharma Inc

13.18.1 Theravance Biopharma Inc Company Information

13.18.2 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Offered

13.18.3 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Theravance Biopharma Inc Main Business Overview

13.18.5 Theravance Biopharma Inc Latest Developments

13.19 Vectura Group Plc

13.19.1 Vectura Group Plc Company Information

13.19.2 Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Offered

13.19.3 Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Vectura Group Plc Main Business Overview

13.19.5 Vectura Group Plc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Tyrosine Protein Kinase JAK1 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Tyrosine Protein Kinase JAK1 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of AZD-4205

Table 4. Major Players of Baricitinib

Table 5. Major Players of Cerdulatinib

Table 6. Major Players of CJ-15314

Table 7. Major Players of Others

Table 8. Global Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)

Table 10. Global Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2022) & ($ million)

Table 11. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2017-2022)

Table 12. Global Tyrosine Protein Kinase JAK1 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)

Table 15. Global Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2022)

Table 16. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2017-2022)

Table 17. Global Tyrosine Protein Kinase JAK1 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Tyrosine Protein Kinase JAK1 Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Company (2020-2022)

Table 20. Global Tyrosine Protein Kinase JAK1 Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company (2020-2022)

Table 22. Global Tyrosine Protein Kinase JAK1 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Tyrosine Protein Kinase JAK1 Producing Area Distribution and Sales Area

Table 24. Players Tyrosine Protein Kinase JAK1 Products Offered

Table 25. Tyrosine Protein Kinase JAK1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Tyrosine Protein Kinase JAK1 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Tyrosine Protein Kinase JAK1 Sales Market Share Geographic Region (2017-2022)

Table 30. Global Tyrosine Protein Kinase JAK1 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Tyrosine Protein Kinase JAK1 Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Country/Region (2017-2022)

Table 34. Global Tyrosine Protein Kinase JAK1 Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2017-2022)

Table 38. Americas Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Tyrosine Protein Kinase JAK1 Revenue Market Share by Country (2017-2022)

Table 40. Americas Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)

Table 42. Americas Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)

Table 44. APAC Tyrosine Protein Kinase JAK1 Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Region (2017-2022)

Table 46. APAC Tyrosine Protein Kinase JAK1 Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Tyrosine Protein Kinase JAK1 Revenue Market Share by Region (2017-2022)

Table 48. APAC Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)

Table 50. APAC Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)

Table 52. Europe Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2017-2022)

Table 54. Europe Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Tyrosine Protein Kinase JAK1 Revenue Market Share by Country (2017-2022)

Table 56. Europe Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)

Table 58. Europe Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Tyrosine Protein Kinase JAK1

Table 69. Key Market Challenges & Risks of Tyrosine Protein Kinase JAK1

Table 70. Key Industry Trends of Tyrosine Protein Kinase JAK1

Table 71. Tyrosine Protein Kinase JAK1 Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Tyrosine Protein Kinase JAK1 Distributors List

Table 74. Tyrosine Protein Kinase JAK1 Customer List

Table 75. Global Tyrosine Protein Kinase JAK1 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Tyrosine Protein Kinase JAK1 Sales Market Forecast by Region

Table 77. Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Tyrosine Protein Kinase JAK1 Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Tyrosine Protein Kinase JAK1 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Tyrosine Protein Kinase JAK1 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Tyrosine Protein Kinase JAK1 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Tyrosine Protein Kinase JAK1 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Tyrosine Protein Kinase JAK1 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Tyrosine Protein Kinase JAK1 Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Tyrosine Protein Kinase JAK1 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Tyrosine Protein Kinase JAK1 Revenue Market Share Forecast by Application (2023-2028)

Table 95. AbbVie Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 96. AbbVie Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 97. AbbVie Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. AbbVie Inc Main Business

Table 99. AbbVie Inc Latest Developments

Table 100. Aclaris Therapeutics Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 101. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 102. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Aclaris Therapeutics Inc Main Business

Table 104. Aclaris Therapeutics Inc Latest Developments

Table 105. Astellas Pharma Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 106. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 107. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Astellas Pharma Inc Main Business

Table 109. Astellas Pharma Inc Latest Developments

Table 110. AstraZeneca Plc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 111. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Offered

Table 112. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. AstraZeneca Plc Main Business

Table 114. AstraZeneca Plc Latest Developments

Table 115. Bristol-Myers Squibb Co Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 116. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Offered

Table 117. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Bristol-Myers Squibb Co Main Business

Table 119. Bristol-Myers Squibb Co Latest Developments

Table 120. Chipscreen Biosciences Ltd Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 121. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Offered

Table 122. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Chipscreen Biosciences Ltd Main Business

Table 124. Chipscreen Biosciences Ltd Latest Developments

Table 125. CJ HealthCare Corp Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 126. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Offered

Table 127. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. CJ HealthCare Corp Main Business

Table 129. CJ HealthCare Corp Latest Developments

Table 130. Concert Pharmaceuticals Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 131. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 132. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Concert Pharmaceuticals Inc Main Business

Table 134. Concert Pharmaceuticals Inc Latest Developments

Table 135. Eli Lilly and Co Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 136. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Offered

Table 137. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Eli Lilly and Co Main Business

Table 139. Eli Lilly and Co Latest Developments

Table 140. Galapagos NV Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 141. Galapagos NV Tyrosine Protein Kinase JAK1 Product Offered

Table 142. Galapagos NV Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Galapagos NV Main Business

Table 144. Galapagos NV Latest Developments

Table 145. Incyte Corp Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 146. Incyte Corp Tyrosine Protein Kinase JAK1 Product Offered

Table 147. Incyte Corp Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Incyte Corp Main Business

Table 149. Incyte Corp Latest Developments

Table 150. Japan Tobacco Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 151. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 152. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Japan Tobacco Inc Main Business

Table 154. Japan Tobacco Inc Latest Developments

Table 155. Jiangsu Hengrui Medicine Co Ltd Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 156. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Offered

Table 157. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Jiangsu Hengrui Medicine Co Ltd Main Business

Table 159. Jiangsu Hengrui Medicine Co Ltd Latest Developments

Table 160. Nissan Chemical Industries Ltd Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 161. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Offered

Table 162. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Nissan Chemical Industries Ltd Main Business

Table 164. Nissan Chemical Industries Ltd Latest Developments

Table 165. Pfizer Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 166. Pfizer Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 167. Pfizer Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Pfizer Inc Main Business

Table 169. Pfizer Inc Latest Developments

Table 170. Portola Pharmaceuticals Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 171. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 172. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. Portola Pharmaceuticals Inc Main Business

Table 174. Portola Pharmaceuticals Inc Latest Developments

Table 175. Sareum Holdings Plc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 176. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Offered

Table 177. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. Sareum Holdings Plc Main Business

Table 179. Sareum Holdings Plc Latest Developments

Table 180. Theravance Biopharma Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 181. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Offered

Table 182. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 183. Theravance Biopharma Inc Main Business

Table 184. Theravance Biopharma Inc Latest Developments

Table 185. Vectura Group Plc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors

Table 186. Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Offered

Table 187. Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 188. Vectura Group Plc Main Business

Table 189. Vectura Group Plc Latest Developments

List of Figures

Figure 1. Picture of Tyrosine Protein Kinase JAK1

Figure 2. Tyrosine Protein Kinase JAK1 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Tyrosine Protein Kinase JAK1 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Tyrosine Protein Kinase JAK1 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Tyrosine Protein Kinase JAK1 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of AZD-4205

Figure 10. Product Picture of Baricitinib

Figure 11. Product Picture of Cerdulatinib

Figure 12. Product Picture of CJ-15314

Figure 13. Product Picture of Others

Figure 14. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type in 2021

Figure 15. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2017-2022)

Figure 16. Tyrosine Protein Kinase JAK1 Consumed in Cutaneous Lupus Erythematosus

Figure 17. Global Tyrosine Protein Kinase JAK1 Market: Cutaneous Lupus Erythematosus (2017-2022) & (K Pcs)

Figure 18. Tyrosine Protein Kinase JAK1 Consumed in Eosinophilia

Figure 19. Global Tyrosine Protein Kinase JAK1 Market: Eosinophilia (2017-2022) & (K Pcs)

Figure 20. Tyrosine Protein Kinase JAK1 Consumed in Hairy Cell Leukemia

Figure 21. Global Tyrosine Protein Kinase JAK1 Market: Hairy Cell Leukemia (2017-2022) & (K Pcs)

Figure 22. Tyrosine Protein Kinase JAK1 Consumed in Others

Figure 23. Global Tyrosine Protein Kinase JAK1 Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)

Figure 25. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application in 2021

Figure 26. Tyrosine Protein Kinase JAK1 Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company in 2021

Figure 28. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Geographic Region in 2021

Figure 30. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Region (2017-2022)

Figure 31. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Country/Region in 2021

Figure 32. Americas Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)

Figure 33. Americas Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)

Figure 34. APAC Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)

Figure 35. APAC Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)

Figure 36. Europe Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)

Figure 37. Europe Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)

Figure 40. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Country in 2021

Figure 41. Americas Tyrosine Protein Kinase JAK1 Revenue Market Share by Country in 2021

Figure 42. United States Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Region in 2021

Figure 47. APAC Tyrosine Protein Kinase JAK1 Revenue Market Share by Regions in 2021

Figure 48. China Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Country in 2021

Figure 55. Europe Tyrosine Protein Kinase JAK1 Revenue Market Share by Country in 2021

Figure 56. Germany Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue Market Share by Country in 2021

Figure 63. Egypt Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Tyrosine Protein Kinase JAK1 in 2021

Figure 69. Manufacturing Process Analysis of Tyrosine Protein Kinase JAK1

Figure 70. Industry Chain Structure of Tyrosine Protein Kinase JAK1

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390